2007Cancer Biology & TherapyOpen access

Antagonistic drug combinations that select against drug resistance: From bacteria to cancer

Mikhail V. Blagosklonny

Open full text 16 citations

Abstract

Any drug selects for drug resistance. But super-antagonistic drug combinations can select for drug sensitivity. This has important application not only for antibacterial therapy but also for cancer therapy: to control cancer with lesser side effects and to eliminate drug-resistant cancer cells, while sparing sensitive normal cells.

Open-access reader

About this research paper

What this paper is about

Any drug selects for drug resistance. But super-antagonistic drug combinations can select for drug sensitivity. This has important application not only for antibacterial therapy but also for cancer therapy: to control cancer with lesser side effects and to eliminate drug-resistant cancer cells, while sparing sensitive normal cells.

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Any drug selects for drug resistance. But super-antagonistic drug combinations can select for drug sensitivity. This has important application not only for antibacterial therapy but also for cancer therapy: to control cancer with lesser side effects and to eliminate drug-resistant cancer cells, while sparing sensitive normal cells.

Key concepts: Drug, Drug resistance, Cancer, Cancer drugs, Medicine, Pharmacology, Cancer cell, Cancer therapy

Related papers

Back to paper searchBrowse research topicsOriginal source
Antagonistic drug combinations that select against drug resistance: From bacteria to cancer — Research Paper | ScholarLens